Condition: Myopia Progression · Sponsor: IDB VisionCare SDN BHD
This clinical trial is designed to assess the efficacy and safety of Atropine Sulphate 0.025% w/v Eye Drops compared to placebo in a randomized, double-blind, placebo-controlled study for the management of myopia progression in children.
This description comes directly from the study's public registry record.
Nor Syakirah Zainal · +60143213786 · atommy@idbvisioncare.com
Always discuss trial participation with your own doctor first.
| Hospital Pakar Kanak-Kanak UKM | Kuala Lumpur, Cheras, Malaysia | Recruiting |
| Universiti Malaya Medical Centre | Kuala Lumpur, Petaling Jaya, Malaysia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07329777